Overview

Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety and tolerability of NKTR-118 treatment of opioid-induced constipation (OIC) in patients with non-cancer-related pain.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Analgesics, Opioid
Naloxegol